EP1497255A2 - Procedes de preparation de combretastatines - Google Patents

Procedes de preparation de combretastatines

Info

Publication number
EP1497255A2
EP1497255A2 EP03740582A EP03740582A EP1497255A2 EP 1497255 A2 EP1497255 A2 EP 1497255A2 EP 03740582 A EP03740582 A EP 03740582A EP 03740582 A EP03740582 A EP 03740582A EP 1497255 A2 EP1497255 A2 EP 1497255A2
Authority
EP
European Patent Office
Prior art keywords
methoxy
trimethoxy
benzaldehyde
benzyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03740582A
Other languages
German (de)
English (en)
French (fr)
Inventor
Stéphane Mutti
Michel Lavigne
Irina Malejonock
Jean-Paul Casimir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA, Aventis Pharma SA filed Critical Rhone Poulenc Rorer SA
Priority to EP10183123A priority Critical patent/EP2348012A1/fr
Priority to EP10183135A priority patent/EP2354118A1/fr
Publication of EP1497255A2 publication Critical patent/EP1497255A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
EP03740582A 2002-04-11 2003-04-09 Procedes de preparation de combretastatines Withdrawn EP1497255A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP10183123A EP2348012A1 (fr) 2002-04-11 2003-04-09 Procede de preparation de combretastatine
EP10183135A EP2354118A1 (fr) 2002-04-11 2003-04-09 Procédé de préparation de combretastatine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0204499 2002-04-11
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines
PCT/FR2003/001117 WO2003084919A2 (fr) 2002-04-11 2003-04-09 Procedes de preparation de combretastatines

Publications (1)

Publication Number Publication Date
EP1497255A2 true EP1497255A2 (fr) 2005-01-19

Family

ID=28459732

Family Applications (3)

Application Number Title Priority Date Filing Date
EP10183123A Withdrawn EP2348012A1 (fr) 2002-04-11 2003-04-09 Procede de preparation de combretastatine
EP03740582A Withdrawn EP1497255A2 (fr) 2002-04-11 2003-04-09 Procedes de preparation de combretastatines
EP10183135A Withdrawn EP2354118A1 (fr) 2002-04-11 2003-04-09 Procédé de préparation de combretastatine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10183123A Withdrawn EP2348012A1 (fr) 2002-04-11 2003-04-09 Procede de preparation de combretastatine

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP10183135A Withdrawn EP2354118A1 (fr) 2002-04-11 2003-04-09 Procédé de préparation de combretastatine

Country Status (28)

Country Link
EP (3) EP2348012A1 (no)
JP (1) JP4299677B2 (no)
KR (1) KR101018983B1 (no)
CN (1) CN1291970C (no)
AR (2) AR039198A1 (no)
AU (1) AU2003260026B2 (no)
BR (1) BR0309087A (no)
CA (1) CA2481742C (no)
CR (1) CR7481A (no)
EA (1) EA007965B1 (no)
EC (1) ECSP045348A (no)
FR (1) FR2838437B1 (no)
HK (1) HK1075651A1 (no)
HR (1) HRP20040935A2 (no)
IL (1) IL164247A0 (no)
MA (1) MA26407A1 (no)
ME (1) MEP91508A (no)
MX (1) MXPA04009112A (no)
NO (2) NO329701B1 (no)
NZ (1) NZ535318A (no)
OA (1) OA12804A (no)
PL (3) PL213708B1 (no)
RS (3) RS52331B (no)
TN (1) TNSN04201A1 (no)
TW (1) TWI262179B (no)
UA (1) UA76079C2 (no)
WO (1) WO2003084919A2 (no)
ZA (1) ZA200407417B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) * 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2011158206A1 (en) 2010-06-18 2011-12-22 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
SU1766257A3 (ru) * 1988-02-24 1992-09-30 Ф.Хоффманн-Ля Рош Аг (Фирма) Способ получени производных стильбена
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
DE69523298T2 (de) * 1994-04-06 2002-06-27 Nippon Shinyaku Co Ltd Aminostilbazolderivate und medikament
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03084919A2 *

Also Published As

Publication number Publication date
RS20110561A2 (en) 2012-10-31
WO2003084919A2 (fr) 2003-10-16
ZA200407417B (en) 2006-04-26
PL371629A1 (en) 2005-06-27
MXPA04009112A (es) 2004-12-07
FR2838437B1 (fr) 2004-06-04
MA26407A1 (fr) 2004-12-01
OA12804A (fr) 2006-07-11
RS86504A (en) 2007-02-05
MEP91508A (en) 2011-12-20
EA007965B1 (ru) 2007-02-27
NO329701B1 (no) 2010-12-06
AR082581A2 (es) 2012-12-19
PL213708B1 (pl) 2013-04-30
NO331372B1 (no) 2011-12-12
CA2481742A1 (fr) 2003-10-16
EP2354118A1 (fr) 2011-08-10
JP4299677B2 (ja) 2009-07-22
CN1646476A (zh) 2005-07-27
NO20101215L (no) 2004-01-07
CN1291970C (zh) 2006-12-27
CA2481742C (fr) 2012-06-19
HK1075651A1 (en) 2005-12-23
PL394820A1 (pl) 2011-09-12
ECSP045348A (es) 2004-11-26
RS20110562A3 (en) 2013-12-31
JP2005522478A (ja) 2005-07-28
RS20110561A3 (en) 2013-10-31
PL214129B1 (pl) 2013-06-28
HRP20040935A2 (en) 2005-10-31
EP2348012A1 (fr) 2011-07-27
TNSN04201A1 (fr) 2007-03-12
UA76079C2 (en) 2006-06-15
BR0309087A (pt) 2005-02-09
NO20044814L (no) 2004-01-07
RS20110562A2 (en) 2012-10-31
FR2838437A1 (fr) 2003-10-17
PL394821A1 (pl) 2011-09-12
AU2003260026B2 (en) 2008-01-03
KR101018983B1 (ko) 2011-03-07
EA200401350A1 (ru) 2005-02-24
TW200401762A (en) 2004-02-01
IL164247A0 (en) 2005-12-18
RS52331B (en) 2012-12-31
WO2003084919A3 (fr) 2004-04-08
TWI262179B (en) 2006-09-21
AU2003260026A1 (en) 2003-10-20
AR039198A1 (es) 2005-02-09
NZ535318A (en) 2007-02-23
PL213967B1 (pl) 2013-05-31
CR7481A (es) 2008-11-25
KR20040108717A (ko) 2004-12-24

Similar Documents

Publication Publication Date Title
EP1497255A2 (fr) Procedes de preparation de combretastatines
EP0927173B1 (fr) [2-(1-piperazinyl)ethoxy]methyle substitues
EP0729936B1 (fr) Procédé de synthèse d'acides acryliques alpha-substitués et N-(mercaptoacyl) amino acides
EP2134673A1 (en) Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
CH688319A5 (fr) Procédé pour la préparation du céfixime trihydraté.
LU81676A1 (fr) Nouveaux derives d'aurones,leur procede de preparation et leur utilisation comme produits pharmaceutiques
EP0303545B1 (fr) Procédé pour la préparation de phényléthanolaminotétralines
WO2008139057A2 (fr) Procede de preparation de 2-(n-butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofurane
EP0002408A1 (fr) Nouveaux composés phénoxy-alcanols substitués, leur procédé de préparation et leur application en thérapeutique
EP1735297B1 (fr) Procede de synthese et intermediaires de benzoxathiepines
CH637125A5 (fr) Procede de preparation du 3-amino-5-(t-butyl)isoxazole.
EP0915867B1 (fr) Derives du thienylcyclohexane pour la synthese de thienylcyclohexyles
WO2011067538A1 (fr) Procede de preparation d'un derive de combretastatine
FR2505329A1 (fr) Esters 2-methoxyphenyliques d'amino-acides n-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
EP2938595B1 (fr) Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome
WO2005058918A1 (fr) Nouveaux derives d’acides phenyl-boronique et leurs procedes de preparation
FR2511677A1 (fr) Procede de preparation d'esters des acides alcoxyvincaminiques et alcoxyapovincaminiques
CA2251637C (fr) Nouveaux [2-(1-piperazinyl)ethoxy]methyle substitues
EP0354078A2 (fr) Nouveaux dérivés du benzocycloheptène, leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2727681A1 (fr) Procede de preparation de derives de pyrrolizine
BE860333A (fr) Derives de l'oxime de l'acide 4-(d-3-amino-3-carboxy-propoxy) phenylglyoxylique
WO2005037756A2 (fr) Nouveaux procedes de preparation de l’acide 4-[4-(4-methoxymethoxy-4’-methyl-biphenyl-2-yl)-but-3-ene-(e)-1-ynyl]-benzoïque
FR2898601A1 (fr) Procede de preparation de derives (2-(2,3-dihydro-benzofuran ou benzofuran-7-yloxy)-ethyl)-(3-cyclopenten-1-yl-benzyl) amines et intermediaire de synthese
JPH07278052A (ja) ２，４−ペンタンジオン誘導体
LU84566A1 (fr) Nouveaux acides carboxyliques heterocycliques et un procede pour les preparer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041111

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

17Q First examination report despatched

Effective date: 20080416

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 213/02 20060101AFI20130307BHEP

Ipc: C07D 263/04 20060101ALI20130307BHEP

Ipc: C07C 217/84 20060101ALI20130307BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20130415

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130817